肌层浸润性膀胱肿瘤保留膀胱手术的治疗进展  

Progress of bladder-sparing surgical treatment for muscle invasive bladder cancer

作　　者：陈伟[1] 杨诚[1] 梁朝朝[1] 

机构地区：[1]安徽医科大学第一附属医院泌尿外科、安徽医科大学泌尿外科研究所,合肥230022

出　　处：《临床泌尿外科杂志》2017年第8期645-648,共4页Journal of Clinical Urology

摘　　要：膀胱肿瘤是泌尿系统常见肿瘤之一,根据肿瘤浸润深度分为肌层浸润性膀胱癌和非肌层浸润性膀胱癌,肌层浸润性膀胱癌约占15%~25%。根治性膀胱切除术加盆腔淋巴结清扫术是肌层浸润性膀胱癌的标准治疗方式。但该手术存在并发症发生率高、严重影响生活质量等问题。近年来,随着技术水平的发展,肌层浸润性膀胱癌保留膀胱的治疗方式逐渐得到了学者们的重视与应用。本文就肌层浸润性膀胱癌保留膀胱的手术治疗进展进行一综述。Bladder cancer is one of the common cancers of the urinary system.It can be divided into muscle invasive bladder cancer（MIBC）and non-muscle invasive bladder cancer according to the depth of tumor invasion,and MIBC accounts for 15%-25% of all cases.Radical cystectomy（RC）with pelvic lymph node dissection remains the gold-standard treatment for MIBC.However,RC shows a high incidence of complications which has corresponding effects on quality of life.In recent years,bladder-sparing techniques for MIBC has been widely accepted and applied.This paper summarized the progress of bladder-sparing surgical treatment for MIBC.

关 键 词：膀胱肿瘤 保留膀胱的手术治疗 根治性膀胱切除术 

分 类 号：R737.14[医药卫生—肿瘤]